Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemia by Florentien E.M. in't Hout, Mylène Gerritsen, Lars Bullinger, Bert A. van der Reijden, Gerwin Huls, Edo Vellenga, Joop H. Jansen

Get full text

CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax by Katharina Mattes, Mylène Gerritsen, Hendrik Folkerts, Marjan Geugien, Fiona A. van den Heuvel, Arthur Flohr Svendsen, Guoqiang Yi, Joost H.A. Martens, Edo Vellenga

Get full text

P455: RUNX1 DIRECTLY BINDS AND REGULATES THE TCF4 PROMOTER by Mylene Gerritsen, Florentien E.M. in ‘t Hout, Ruth G.H.J.N. Knops, Bert A. van der Reijden, Joost H.A. Martens, Joop H Jansen

Get full text

Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern by Gerbrig Berger, Mylene Gerritsen, Guoqiang Yi, Theresia N. Koorenhof-Scheele, Leonie I. Kroeze, Marian Stevens-Kroef, Kenichi Yoshida, Yuichi Shiraishi, Eva van den Berg, Hein Schepers, Geert Huls, André B. Mulder, Seishi Ogawa, Joost H.A. Martens, Joop H. Jansen, Edo Vellenga

Get full text